Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
Patents for C07D 215 - Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems (27,676)
12/2005
12/01/2005US20050267182 Urea derivatives as FLT-3 modulators
12/01/2005US20050267171 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
12/01/2005US20050267163 Vanilloid receptor ligands and their use in treatments
12/01/2005US20050267152 Gly1 transporter inhibitors and uses thereof in treatment of neurological and neuropsychiatric disorders
12/01/2005US20050267126 Compounds derived from aryl carbamates, preparation thereof and uses of same
12/01/2005US20050266457 Modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms
12/01/2005US20050266268 Such as bis(4-biphenyl-4-yl)pyridine-C3-N3)(acetylacetonato-) iridium (III); brightness; phosphorescence; graphic arts
12/01/2005CA2567343A1 N-cyclic sulfonamido inhibitors of gamma secretase
12/01/2005CA2564365A1 Compounds and compositions as ppar modulators
12/01/2005CA2564215A1 Substituted quinoline derivatives as mitotic kinesin inhibitors
11/2005
11/30/2005EP1599450A1 Process for preparing 5-"(r)-2-(5,6-diethyl-indian-2-ylamin o)-1-hydroxy-ethyl!-8-hydroxy-(1h)-quinolin-2-one salt, useful as an adrenoceptor agonist
11/30/2005EP1599449A2 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
11/30/2005EP1599444A1 Sulphonyl hydroxamic acid derivatives as inhibitors of s-cd23
11/30/2005EP1274457B1 Method and compositions for the treatment of allergic conditions using pgd2 receptor antagonists
11/30/2005EP1098864B9 Method for hydrogenating unsaturated heterocyclic compounds
11/30/2005CN1703412A Novel compounds with antibacterial activity
11/30/2005CN1703403A Metabotropic glutamate receptor antagonists
11/30/2005CN1703401A Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/30/2005CN1703397A Sulfonylamino-acetic acid derivatives and their use as orexin receptor antagonists
11/30/2005CN1703395A Aryl and heteroaryl compounds and methods to modulate coagulation
11/29/2005US6969723 preferably antagonists used in the therapeutic and/or preventive treatment of disfunctions of the heart, kidney, respiratory system, central nervous system
11/29/2005US6969713 Piperidine and piperazine acetamide derivatives
11/29/2005US6969710 Compounds
11/29/2005CA2099213C 4-iminoquinolines, processes for their preparation, and their use
11/24/2005WO2005110990A1 Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases
11/24/2005WO2005110989A1 Substituted 1-heteroaryl-4-substituted piperazine and piperidine analogues
11/24/2005WO2005110980A2 Aryl sulfones and uses related thereto
11/24/2005WO2005082856A3 Tetrahydroquinolinones and their use as antagonists of metabotropic glutamate receptors
11/24/2005WO2005077884A3 Hydroaminomethylation of olefins
11/24/2005US20050261496 3-(Morpholin-4-ylsulfonyl)-5-(1,3-thiazol-2-yl)-1H-indole-2-carboxamide; inhibiting, modulating and/or regulating signal transduction of both receptor and non-receptor tyrosine kinases; anticarcinogenic, -diabetic, -arhtritic, -inflammatory agents; psoriasis; angiogenesisinhibitors; liver cirrhosis
11/24/2005US20050261337 Substituted quinoline derivatives
11/24/2005US20050261336 e.g. 8-hydroxy-2-[2-[3,4-dihydroxy-5-methoxyphenyl)ethenyl]]-7-quinoline carboxylic acid; HIV integrase inhibitors; AIDS, retroviral pathologies
11/24/2005US20050261334 Bis-pyridino containing compounds for the use in the treatment of CNS pathologies
11/24/2005US20050261315 tyrosine kinase inhibitors such as N-(3-tert-butylisoxazol-5-yl)-2-(4-(benzyloxy)phenyl)acetamide, used for treating and preventing conditions and diseases, such as cancer, hematologic malignancies, cardiovascular disease, inflammation or multiple sclerosis
11/24/2005US20050261308 1-(2-Chloro-6-piperazin-1-yl-pyrimidin-4-ylmethyl)-3,4-dihydro-1H-quinolin-2-one; substituted benzoxazinone compounds; 5-HT6 modulators/antagonists; Parkinson's disease, Huntington's disease, manic depression, psychoses, Alzheimer's disease and memory disorders
11/24/2005US20050261286 Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament
11/24/2005US20050261276 Novel sulphones for inhibition of gamma secretase
11/24/2005US20050261244 Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
11/24/2005US20050260126 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein
11/24/2005CA2565243A1 Hydroxy-substituted benzo-condensed heterocycles for use as beta agonists in the treatment of respiratory diseases
11/24/2005CA2561525A1 Aryl sulfones and uses related thereto
11/23/2005EP1597322A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
11/23/2005EP1597248A2 Sulfonamide derivatives as ppar modulators
11/23/2005EP1597233A1 Benzyl urea and thiourea derivatives useful as androgen antagonists
11/23/2005EP1596864A2 Flavone acetic acid analogs and methods of use thereof
11/23/2005EP1596860A2 Novel compounds
11/23/2005EP1377550B9 Phenyl heterocyclyl ether derivatives as serotonin re-uptake inhibitors
11/23/2005CN1701061A New compounds for the inhibition of rotamases and use thereof
11/23/2005CN1699346A Low hygroscopic aripiprazole drug substance and processes for the preparation thereof
11/23/2005CN1228327C Carboxylic acid derivatives and drugs containing the same
11/23/2005CN1228287C Continuous selection wrapping separation method and equipment therefor
11/22/2005US6967209 Processes for preparing 6-hydroxy-3,4-dihydroquinolinone, cilostazol and N-(4-methoxyphenyl)-3-chloropropionamide
11/22/2005US6967205 Compounds with antibacterial and antiparasitic properties
11/17/2005WO2005108617A2 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/17/2005WO2005108404A1 Heavy metal complex of ethynyl group-substituted fused heterocyclic compound, method for producing same, synthetic intermediate thereof, method for producing same, and organic electroluminescent device
11/17/2005WO2005108381A1 Synthesis and uses of synephrine derivatives
11/17/2005WO2005108372A1 Process to make metal complexes with volatile liquid metal compounds
11/17/2005WO2005108371A1 Method for stabilization of ethoxyquin, and aqueous c1-c3 carboxylic acid - containing solutions comprising ethoxyquin as antioxidant
11/17/2005WO2005108370A1 Benzene compounds
11/17/2005WO2005058834A3 Quinolines useful in treating cardiovascular disease
11/17/2005WO2005051906A3 Heterocyclic inhibitors of mek and methods of use thereof
11/17/2005WO2005016264A3 Diamine derivatives of quinone and uses thereof
11/17/2005US20050256161 Melanin concentrating hormone receptor antagonists
11/17/2005US20050256158 PGD2 receptor antagonists for the treatment of inflammatory diseases
11/17/2005US20050256156 Processes for preparing montelukast sodium
11/17/2005US20050256132 Use of ER selective NF-kB inhibitors for the treatment of sepsis
11/17/2005US20050256118 Bicyclic-substituted amines having cyclic-substituted monocyclic substituents
11/17/2005CA2563521A1 Mutant receptors and their use in a nuclear receptor-based inducible gene expression system
11/16/2005EP1595871A2 Metabotropic glutamate receptor antagonists and their use for treating central nervous system diseases
11/16/2005EP1594844A1 Substituted quinoline-4-carboxylic hydrazides as nk-2/nk-3 receptor ligands
11/16/2005EP1594843A2 Method for producing an optically active tetrahydroquinoline
11/16/2005EP1594502A1 4- (2,4-dichloro-5-methoxyphenyl)amino -6-alkoxy-3-quinolinecarbonitriles for the treatment of ischemic injury
11/16/2005EP1594501A2 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
11/16/2005EP1511395A4 Method of extracting rutin from buck wheat growed by hydroponics
11/16/2005EP1476429B1 Novel pyridine- and quinoline-derivatives
11/16/2005EP0834074B2 Detection of transmembrane potentials by optical methods
11/16/2005CN1227244C Herbicidal benzoyl derivatives
11/15/2005US6964973 Nonsteroidal agonists and antagonists
11/15/2005US6964966 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections
11/10/2005WO2005105764A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005WO2005105751A1 Processes for preparing montelukast sodium
11/10/2005WO2005105750A1 Process for making montelukast and intermediates therefor
11/10/2005WO2005105749A2 Process for making montelukast and intermediates therefor
11/10/2005WO2005105724A1 Hexenoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications thereof
11/10/2005WO2005095326A3 2-amino- and 2-thio-substituted 1,3-diaminopropanes
11/10/2005WO2005075429B1 Novel quinoline-carbaxamides as jack3 kinase modulators
11/10/2005US20050250959 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds
11/10/2005US20050250944 Synthesis and uses of synephrine derivatives
11/10/2005US20050250814 Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity
11/10/2005US20050250809 Reacting chloroperbenzoic acid with 3-dichloromethylthio-7-fluoro-1-,ethyl-4-quinolone in dichloromethane;
11/10/2005US20050250782 Heterocyclic inhibitors of MEK and methods of use thereof
11/10/2005US20050250743 Ammonium salts of inositol hexaphosphate, and uses thereof
11/10/2005US20050248263 Blue emitting tris (8-oxoquinoline) aluminum (III) (alq3)
11/10/2005CA2565184A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof
11/10/2005CA2563776A1 Processes for preparing montelukast sodium
11/09/2005EP1592684A1 Malonamide derivatives as gamma-secretase inhibitors
11/09/2005EP1592668A1 Crystalline forms of pitavastatin calcium
11/09/2005EP1254118B1 Substituted 1,2,3,4- tetrahydroquinoline-2-carboxylic acid derivatives
11/09/2005EP1095016B1 Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
11/09/2005CN1694873A Vanilloid receptor ligands and their use in treatments
1 ... 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 ... 277